increas
number
studi
support
import
role
thiol
disulfid
exchang
entri
multipl
virus
suscept
cell
includ
sindbi
viru
baculoviru
vaccinia
viru
equin
arter
viru
moloney
murin
leukemia
viru
newcastl
diseas
viru
hepat
delta
viru
review
entri
requir
attach
subunit
viral
envelop
env
glycoprotein
primari
receptor
interact
induc
structur
rearrang
env
expos
conserv
region
within
subunit
therebi
enabl
bind
appropri
coreceptor
primarili
chemokin
receptor
engag
coreceptor
trigger
conform
chang
subunit
expos
hydrophob
aminotermin
fusion
peptid
insert
host
cell
membran
follow
format
six
helix
bundl
trimerofhairpin
structur
enabl
fusion
viru
cell
membran
subsequ
releas
viral
capsid
cytosol
review
env
contain
disulfid
bond
nine
one
subunit
respect
observ
potent
suppress
infect
disulfid
isomeras
inhibitor
reveal
import
thioldisulfid
exchang
viru
entri
present
still
ambigu
regard
enzym
mediat
disulfid
bond
rearrang
major
studi
investig
effect
disulfid
isomerasereductas
inhibitor
specif
polyclon
monoclon
antibodi
ab
direct
enzym
well
fluoresc
microscopi
western
blot
analysi
interact
andor
reduct
disulfid
bond
impli
pdi
key
enzym
involv
entri
process
howev
also
report
trx
play
major
role
env
induc
fusion
pdi
express
andor
function
neglig
effect
yet
anoth
studi
shown
anoth
member
trx
superfamili
reduc
disulfid
bond
inhibit
result
reduc
infect
thu
signific
thioldisulfid
exchang
process
infect
establish
predominantli
use
cell
line
laboratoryadapt
strain
limit
number
studi
employ
primari
human
cell
andor
isol
strain
primarili
involv
viru
transmiss
predomin
earli
asymptomat
stage
infect
typic
present
throughout
symptomat
phase
hiv
diseas
review
reason
conduct
comprehens
studi
use
panel
distinct
assay
focu
extens
signific
thioldisulfid
exchang
entri
sever
strain
includ
minim
passag
natur
target
primari
human
macrophag
lymphocyt
addit
determin
effect
disulfid
reductaseisomeras
inhibitor
human
macrophag
infect
one
primari
strain
capabl
infect
cell
result
provid
critic
new
inform
role
disulfid
isomeras
hiv
infect
support
previou
observ
thioldisulfid
exchang
requir
entri
interestingli
data
reveal
celltyp
specif
respect
enzym
involv
process
initi
examin
effect
nonspecif
thioldisulfid
exchang
inhibitor
dtnb
infect
differ
cell
type
luciferas
luc
report
geneencod
env
pseudotyp
viru
particl
sinc
particl
compet
singl
cycl
infect
produc
use
backbon
plasmid
applic
allow
accur
assess
effect
dtnb
distinct
envpseudotyp
virion
andor
experiment
cell
system
brief
preincub
h
cell
infect
presenc
dtnb
h
follow
extens
washout
reagent
h
later
cell
lyse
luc
activ
measur
express
rel
light
unit
rlu
ho
cell
dtnb
exposur
potent
reduc
infect
envpseudotyp
virion
figur
without
impair
cell
viabil
trypan
blue
exclus
test
dtnb
also
caus
similar
dosedepend
suppress
envpseudotyp
virion
infect
cell
line
well
primari
macrophag
pbmc
figur
c
without
significantli
alter
cell
surfac
express
chemokin
coreceptor
data
shown
dtnb
incub
also
effect
luc
activ
cell
directli
electropor
er
luc
plasmid
use
gener
report
geneencod
env
pseudotyp
viru
particl
data
shown
consist
previou
observ
dtnb
nearli
plasma
membran
imperm
welldocu
life
cycl
involv
multipl
step
includ
viral
envmedi
membran
fusion
uncoat
viral
rna
revers
transcript
provir
dna
integr
transcript
translat
well
viral
particl
assembl
bud
given
dtnb
could
potenti
interfer
multipl
cell
surfac
protein
contain
sulphydryl
group
although
unlik
still
possibl
effect
dtnb
replic
could
nonspecif
reason
sought
examin
effect
dtnb
sole
viru
entri
employ
blam
contain
virion
prior
test
effect
spread
infect
vitro
neg
control
prepar
dtnb
treat
untreat
cell
confirm
dtnb
detriment
effect
load
cell
fluoresc
dye
influenc
background
nonspecif
cell
fluoresc
figur
b
upper
graph
addit
cell
electropor
zeo
vprblam
incub
mm
dtnb
subsequ
load
fluoresc
dye
show
signific
differ
number
blue
cell
compar
cell
incub
dmem
data
shown
indic
dtnb
affect
blam
enzymat
activ
use
blam
contain
viru
particl
establish
dtnb
significantli
inhibit
fusion
blamcontain
virion
cell
line
figur
primari
human
pbmc
figur
well
mdm
figur
indic
effect
occur
predominantli
level
viru
entri
support
role
thioldisulfid
exchang
env
infect
next
determin
effect
dtnb
wt
infect
human
mdm
laboratori
adapt
strain
minim
passag
isol
well
primari
strain
dtnb
abl
suppress
infect
three
isol
level
revers
transcriptas
activ
approach
observ
uninfect
control
mdm
indic
effect
strain
specif
figur
b
c
identifi
disulfid
reductasesisomeras
involv
infect
mdm
serv
potenti
target
dtnb
effect
specif
monoclon
antibodi
mab
pdi
andor
trx
two
enzym
previous
implic
env
disulfud
bond
rearrang
evalu
mab
appli
viru
adsorptionfus
infect
monitor
measur
rt
activ
variou
time
point
throughout
cours
infect
antipdi
antitrx
mab
significantli
inhibit
mdm
infect
three
strain
test
howev
data
obtain
multipl
experi
perform
establish
antitrx
mab
effici
reduc
rt
valu
delay
time
peak
rt
activ
infect
figur
e
data
shown
suggest
trx
may
play
greater
role
disulfid
bond
rearrang
isol
next
investig
role
pdi
andor
trx
viru
entri
infect
cell
line
known
natur
express
infect
well
strain
found
antipdi
mab
inhibit
infect
cell
env
pseudotyp
luc
report
gene
viru
particl
dose
depend
manner
figur
contrast
antitrx
mab
effect
latter
infect
even
use
maximum
concentr
similar
result
obtain
antipdi
andor
antitrx
treat
cell
infect
env
pseudotyp
virion
data
shown
furthermor
antipdi
mab
antitrx
mab
significantli
reduc
rt
valu
delay
peak
rt
activ
cell
infect
laboratoryadapt
strain
strain
figur
c
although
affin
valu
mab
could
obtain
commerci
sourc
establish
kd
valu
antipdi
antitrx
mab
nm
nm
respect
use
surfac
plasmon
reson
data
shown
affin
two
mab
well
length
incub
h
preincub
plu
addit
h
viru
adsorptioninfect
suggest
compar
bind
two
mab
relev
target
especi
use
highest
concentr
igg
subsequ
find
cell
primari
human
pha
stimul
pbl
infect
envpseudotyp
luc
report
gene
viru
particl
presenc
absenc
antipdi
antitrx
mab
expect
consist
observ
use
cell
line
antipdi
antitrx
mab
reduc
luc
report
gene
activ
primari
pbl
isol
four
differ
donor
figur
primari
mdm
evalu
effect
antipdi
antitrx
mab
envpseudotyp
viru
infect
use
experiment
system
contrast
primari
human
pbl
antitrx
mab
effect
inhibit
infect
primari
mdm
present
viru
adsorpt
entri
period
opposit
trend
statist
signific
differ
establish
antipdi
antitrx
treat
cell
pbl
mdm
system
respect
figur
given
mean
luc
activ
nonspecif
igg
treat
cell
assum
possibl
directli
evalu
statist
signific
p
valu
differ
control
antipdi
control
antitrx
treat
cell
figur
howev
differ
control
antipdi
treat
pbl
control
antitrx
treat
mdm
found
statist
signific
donor
test
primari
data
rlu
use
calcul
relev
p
valu
shown
attempt
delin
basi
observ
celltyp
specif
requir
thioldisulfid
exchang
viru
entri
cell
surfac
express
pdi
trx
assess
variou
cell
type
use
infect
mab
clone
use
inhibit
infect
directli
conjug
differ
fluoresc
dye
antipdi
dylight
antitrxapc
use
flow
cytometri
analysi
although
pdi
trx
predominantli
found
intracellular
protein
welldocu
molecul
also
secret
associ
plasma
membran
given
cell
surfac
pdi
trx
molecul
peripher
plasma
membran
protein
cell
prepar
flow
cytometri
analysi
cell
surfac
pdi
trx
wash
dpb
fix
paraformaldehyd
prior
label
prevent
dissoci
cell
surfac
treat
quench
reactiv
aldehyd
group
incub
specif
mab
describ
method
addit
antipdi
antitrx
mab
pbl
also
incub
specif
mab
directli
label
fluoresc
marker
pacif
blue
cell
stain
posit
analyz
pdi
trx
cell
surfac
level
found
cell
primari
mdm
express
pdi
trx
surfac
figur
b
intriguingli
contrast
pdi
present
compar
level
unstimul
phaactiv
cell
trx
express
low
unstimul
lymphocyt
increas
significantli
pha
treatment
figur
taken
togeth
find
strongli
suggest
cell
type
specif
effect
antipdi
antitrx
mab
observ
cell
primari
mdm
pha
activ
pbl
attribut
absenc
enzym
plasma
membran
variou
cell
test
grow
evid
thioldisulfid
exchang
requir
complex
conform
chang
occur
viruscel
fusion
matur
env
express
trimer
heterodim
surfac
virion
andor
infect
cell
consist
five
variabl
domain
interconnect
five
conserv
region
delin
nine
intrachain
disulfid
bond
ectodomain
addit
hydrophob
nterminu
encompass
two
hydrophob
region
characterist
coiledcoil
structur
design
heptad
repeat
connect
linker
sequenc
form
conserv
disulfid
bond
although
publish
report
sever
independ
studi
topic
number
locat
time
env
disulfid
bond
modif
viru
entri
still
complet
elucid
major
disulfid
bond
delin
insid
domain
well
disulfid
bond
implic
potenti
target
reduct
andor
isomer
ambigu
respect
disulfid
bond
rearrang
take
place
immedi
follow
bind
interact
relev
coreceptor
reason
suggest
disulfid
bond
could
modifi
right
bind
rearrang
facilit
subsequ
coreceptor
associ
other
disulfid
bond
straddl
loop
critic
integr
coreceptor
bind
site
may
undergo
modif
complex
form
also
report
disulfid
bond
second
immunoglobulinlik
domain
undergo
redox
chang
necessari
entri
similar
situat
env
precis
time
role
redox
modif
process
viru
fusion
remain
incomplet
character
present
consensu
regard
particular
disulfid
reductasesisomeras
may
requir
infect
experiment
data
variou
studi
confirm
pdi
mediat
disulfid
bond
rearrang
well
suppress
infect
pdi
inhibitor
howev
trx
also
shown
induc
redox
chang
ou
et
al
found
trx
pdi
play
major
role
envmedi
fusion
interestingli
recent
report
despit
certain
quantit
differ
pdi
trx
gener
target
disulfid
bond
within
auwerx
et
al
establish
anoth
oxidoreductas
addit
pdi
caus
disulfid
bond
reduct
also
observ
signific
incomplet
inhibit
infect
polyclon
ab
given
report
effect
disulfid
reductaseisomeras
inhibitor
infect
primari
human
cell
current
studi
set
provid
comprehens
investig
role
thioldisulfid
exchang
infect
use
primari
human
pbmc
pbl
mdm
use
singl
cycl
well
multiround
replic
assay
initi
test
effect
nonspecif
disulfid
isomerasereductas
inhibitor
dtnb
employ
predominantli
strain
contrast
virus
hantavirus
surfac
glycoprotein
express
free
thiol
group
unlik
dtnb
interact
directli
env
sinc
cystein
interlink
via
disulfid
bond
howev
reductas
activ
complet
suppress
viruscel
fusion
process
especi
lower
dtnb
concentr
appli
potenti
alkyl
dtnb
newli
gener
thiol
group
may
contribut
inhibitori
activ
establish
dtnb
potent
reduc
entri
infect
primari
cell
level
compar
observ
inhibit
cell
line
figur
dtnb
also
inhibit
mdm
infect
strain
test
includ
primari
minim
passag
strain
strain
attempt
identifi
particular
disulfid
reductasesisomeras
involv
entri
appli
specif
mab
unexpectedli
reveal
clearli
distinguish
specif
among
variou
cell
type
test
figur
mdm
antitrx
mab
prove
potent
antipdi
mab
suppress
entri
infect
contrast
antitrx
mab
neglig
effect
cell
line
primari
pbl
antipdi
mab
significantli
reduc
infect
cell
figur
intriguingli
pdi
trx
present
plasma
membran
cell
type
test
figur
although
appear
mdm
display
higher
level
trx
pdi
surfac
unlik
fact
alon
could
account
differ
inhibitori
activ
antitrx
antipdi
mab
support
notion
cell
pha
stimul
pbl
express
compar
level
trx
pdi
surfac
antipdi
antitrx
mab
clearli
exert
distinct
pattern
infect
compar
effect
primari
human
mdm
figur
previous
shown
pdi
coloc
cell
surfac
specul
preferenti
tempor
associ
relev
corecepor
either
pdi
trx
might
reason
observ
celltyp
specif
oxidoreductas
involv
entri
molecular
dock
analysi
reveal
pdi
may
interact
third
immunoglobulinlik
region
contain
one
glycosyl
site
human
conceiv
subtl
differ
glycosyl
may
result
preferenti
interact
pdi
cell
type
other
also
known
interact
tyrosin
kinas
pbl
cell
line
monocyt
mdm
may
also
influenc
behavior
cell
surfac
celltyp
depend
manner
heterogen
well
preferenti
cell
type
depend
interact
may
also
contribut
factor
celltyp
specif
disulfid
reductaseisomeras
involv
entri
altern
combin
paramet
alreadi
discuss
may
differ
way
lymphocytest
cell
line
macrophag
regul
balanc
oxid
reduc
form
pdi
andor
trx
surfac
turn
may
favor
preferenti
involv
one
enzym
entri
cell
surfac
molecul
may
also
interact
pdi
trx
influenc
redox
statu
andor
avail
entri
recent
report
bind
increas
retent
pdi
cell
surfac
thu
facilit
lymphocyt
migrat
infect
like
modul
cell
surfac
redox
environ
evid
addit
pdi
trx
may
disulfid
reductas
like
particip
envmedi
fusion
whether
altern
disulfid
reductasesisomeras
display
celltyp
specif
activ
remain
establish
interestingli
pdi
figur
significantli
incomplet
reduc
infect
pbl
andor
pbmc
suggest
certain
oxidoreductas
may
substitut
entri
final
look
result
perspect
infect
vivo
attempt
better
understand
pathogenesi
redox
imbal
hallmark
infect
result
complex
chain
event
intra
extracellular
level
influenc
replic
review
find
freshli
isol
pbl
contrast
phastimul
cell
express
ampl
amount
pdi
yet
express
rel
low
level
trx
surfac
may
provid
insight
regard
predomin
util
pdi
lymphocyt
entri
rest
cell
establish
viru
reservoir
given
mdm
util
predominantli
trx
entri
figur
e
observ
elev
plasma
trx
chronic
stage
hiv
diseas
may
enhanc
macrophag
infect
help
sustain
high
viremia
even
low
level
tcell
exist
regard
plasma
trx
level
show
signific
invers
correl
surviv
rate
patient
cell
count
enorm
potenti
mutat
abil
establish
longlast
viral
reservoir
current
imposs
complet
erad
even
highli
activ
antiretrovir
therapi
haart
along
emerg
resist
strain
antagonist
maraviroc
selzentri
review
andor
fusion
inhibitor
enfuvirtid
emphas
import
develop
new
effect
therapi
suppress
viru
entri
therefor
identif
conserv
host
cellular
factor
disulfid
reductas
isomeras
involv
pathogenesi
increas
understand
mechan
action
may
facilit
futur
develop
new
antivir
modal
find
clearli
establish
role
thioldisulfid
exchang
entri
infect
primari
cell
mdm
varieti
strain
includ
isol
minim
passag
regard
involv
particular
disulfid
isomerasesreductas
process
result
also
demonstr
celltyp
depend
specif
may
provid
explan
differ
among
previous
publish
studi
vivo
perspect
preferenti
util
pdi
may
relev
entri
establish
viru
reservoir
rest
cell
elev
level
trx
report
chronic
stage
infect
may
facilit
viru
entri
macrophag
help
sustain
high
viremia
declin
lymphocyt
dithiobi
acid
dtnb
purchas
sigmaaldrich
st
loui
mo
fetal
bovin
serum
fb
obtain
hyclon
logan
ut
phosphat
buffer
salin
pb
rpmi
medium
purchas
lonza
walkersvil
md
phenol
redfre
dulbecco
modifi
eagl
medium
dmem
hepe
buffer
solut
load
kit
geneblaz
report
assay
purchas
invitrogen
corp
carlsbad
ca
penicillinstreptomycin
antibiot
solut
respect
sodium
pyruv
mm
dulbecco
phosphat
buffer
salin
dpb
lglutamin
mm
obtain
lonza
walkersvil
md
luciferas
assay
system
fugen
transfect
reagent
purchas
promega
corp
madison
wi
roch
appli
scienc
indianapoli
respect
viru
stock
purchas
advanc
biotechnolog
columbia
md
unaid
network
hiv
isol
character
daid
niaid
receiv
aid
research
refer
reagent
program
niaid
nih
plasmid
er
luc
zeo
vprblam
provid
dr
r
dom
univ
penn
dr
g
quinnan
usuh
bethesda
md
dr
miller
merck
co
inc
west
point
pa
respect
mous
monoclon
antipdi
antibodi
mab
clone
polyclon
rabbit
antipdi
antibodi
pab
purchas
enzo
life
scienc
formerli
stressgen
assay
design
ann
arbor
mi
mous
antihuman
trx
mab
clone
obtain
abd
serotec
raleigh
nc
unlabel
pacif
blue
fitc
conjug
isotyp
igg
control
antihuman
clone
antihuman
clone
antihuman
clone
goat
antimous
f
ab
purchas
ebiosci
san
diego
ca
bd
bioscienc
san
jose
ca
life
technolog
grand
island
ny
human
fcr
block
reagent
purchas
miltenyi
biotec
auburn
ca
lynx
rapid
apc
antibodi
conjug
kit
obtain
fron
abd
serotec
ho
cell
line
obtain
dr
g
quinnan
usuh
bethesda
md
dr
dimitrov
nci
frederick
aid
research
refer
reagent
program
niaid
nih
dr
reitz
american
type
cultur
collect
atcc
respect
cell
line
maintain
dmem
ho
supplement
fc
mm
lglutamin
antibiot
humidifi
atmospher
human
pbmc
isol
ficollpaquetm
gradient
centrifug
leukapheresi
healthi
human
donor
seroneg
hepat
b
hepat
c
monocyt
lymphocyt
separ
use
countercurr
centrifug
cell
elutri
previous
describ
luc
report
gene
blam
entri
assay
macrophag
prepar
elutri
monocyt
differenti
mm
squar
petri
dish
bibbi
sterilin
ltd
stone
staff
uk
dmem
supplement
human
serum
pool
multipl
normal
donor
mm
lglutamin
antibiot
medium
human
mdm
obtain
day
differenti
absenc
exogen
growth
factor
either
use
immedi
differenti
period
kept
frozen
liquid
nitrogen
day
experi
frozen
cell
thaw
wash
centrifug
resuspend
medium
prior
incub
overnight
wild
type
wt
infect
experi
monocyt
differenti
day
tissu
cultur
plate
costar
harvest
replat
plate
nunc
roskild
denmark
h
prior
infect
x
cellswel
ml
medium
pbl
either
kept
frozen
use
immedi
elutri
stimul
h
phap
sigmaaldrich
st
loui
mo
pbl
wash
count
infect
env
pseudotyp
blamcontain
virion
well
plate
cellswel
experi
perform
use
biacor
system
ge
healthcar
two
mab
test
immobil
sensor
either
directli
antitrx
indirectli
antipdi
via
antimous
fc
rabbit
igg
jackson
immunoresearch
laboratori
west
grove
pa
antitrx
mab
rabbit
antimous
fc
igg
crosslink
sensor
use
amin
coupl
kit
ge
healthcar
human
recombin
trx
pdi
obtain
sigmaaldrich
st
loui
mo
enzo
life
scienc
farmingdal
ny
respect
bind
relev
mab
test
concentr
rang
nm
cycl
surfac
sensor
regener
appli
low
ph
glycin
buffer
effici
regener
procedur
verifi
prior
pilot
experi
gener
data
evalu
use
biacor
softwar
kinet
analysi
pdi
detect
use
directli
conjug
mab
clone
pacif
blue
bd
pharmingen
antipdi
clone
dylight
assay
design
respect
relev
isotyp
control
obtain
compani
antitrx
mab
clone
abd
serotec
relev
isotyp
control
igg
label
fluoresc
dye
apc
use
lynx
rapid
apc
antibodi
conjug
kit
follow
manufactur
instruct
abd
serotec
nonoverlap
emiss
excit
spectra
pacif
blue
dylight
apc
allow
simultan
label
three
differ
mab
subsequ
flow
cytometri
analysi
minim
interfer
cell
primari
human
lymphocyt
wash
dpb
fix
paraformaldehyd
wash
dpb
incub
min
mm
quench
free
aldehyd
group
reduc
unspecif
antibodi
bind
primari
mdm
treat
ident
detach
plastic
wash
incub
dpb
free
follow
pipet
gentl
scrape
necessari
cell
wash
dpb
incub
overnight
dpb
plu
bovin
serum
albumin
bsa
subsequ
cell
label
simultan
antipdi
antitrx
mab
relev
isotyp
control
h
dpb
bsa
mab
per
cell
wash
time
dpb
analyz
use
lsr
ii
bd
cell
analyz
detect
andor
cell
initi
label
relev
antibodi
ice
subsequ
fix
paraformaldehyd
flow
cytometri
analysi
detect
either
use
conjug
specif
antibodi
bd
bioscienc
use
nonconjug
clone
clone
mab
follow
goat
antimous
fitcconjug
igg
f
ab
life
technolog
ny
report
gene
pseudotyp
system
viral
stock
prepar
transfect
cell
plasmid
encod
luc
viru
backbon
er
transfect
cell
wash
extens
dmem
incub
h
result
supernat
clarifi
centrifug
min
rpm
filter
low
protein
bind
syring
filter
millipor
bedford
use
immedi
kept
h
posit
cell
prepar
cellswel
well
cellswel
plate
infect
viru
suspens
per
well
respect
deaedextran
polybren
use
facilit
fusion
dtnb
antipdi
antitrx
mab
serum
free
dmem
appli
indic
figur
legend
h
period
viru
infect
serum
free
medium
cell
extens
wash
incub
h
medium
supplement
fb
prior
lysi
pb
luc
report
gene
studi
aliquot
result
lysat
assay
luc
activ
use
appropri
substrat
promega
madison
wi
exclud
possibl
dtnb
effect
luc
express
postentri
level
ho
cell
electropor
er
plasmid
incub
h
next
day
concentr
dtnb
use
viru
infect
experi
lyse
test
luc
activ
h
later
statist
analysi
experi
employ
env
pseudotyp
luc
report
gene
encod
viru
particl
perform
use
graphpad
prism
scientif
softwar
ttest
blamcontain
viru
particl
produc
cotransfect
cell
plasmid
encod
provir
dna
construct
encod
blam
fuse
aminoterminu
viral
protein
vpr
direct
blam
form
virion
preincub
infect
h
serum
free
medium
cell
extens
wash
load
fluoresc
dye
final
concentr
h
wash
remov
extracellular
dye
incub
phenol
red
free
dmem
plu
fc
mm
lglutamin
mm
hepe
presenc
nonspecif
anion
transport
inhibitor
probenecid
mm
h
prior
fix
paraformaldehyd
extent
cleavag
virusintroduc
intracellular
blam
detect
chang
dye
emiss
green
blue
spectrum
evalu
measur
fluoresc
use
laser
scan
cytomet
compucyt
cambridg
bd
lsr
ii
cell
analyz
gener
light
nm
equip
filter
detect
blue
green
emiss
respect
individu
neg
control
mock
infect
prepar
medium
dtnbtreat
cell
defin
precis
region
blam
posit
cell
laser
scan
flow
cytometri
experi
exclud
possibl
dtnb
effect
blam
activ
ho
andor
cell
electropor
parent
vprblam
encod
plasmid
incub
h
next
day
mm
dtnb
wash
load
fluoresc
dye
analyz
flow
cytometri
describ
viru
entri
experi
h
seed
well
plate
macrophag
wash
incub
min
differ
disulfid
reductaseisomeras
inhibitor
appropri
control
infect
h
select
strain
presenc
reagent
subsequ
cell
wash
incub
medium
without
disulfid
reductas
inhibitor
progress
viru
replic
monitor
measur
revers
transcriptas
rt
activ
follow
everi
day
cultur
medium
harvest
replac
collect
medium
store
evalu
follow
preincub
minut
mm
dtnb
antipdi
antitrx
mab
cell
infect
panel
b
panel
c
well
plate
infect
h
presenc
aforement
inhibitor
cell
wash
incub
without
dtnb
mab
cell
cultur
supernat
collect
everi
two
day
cryopreserv
evalu
rt
activ
rt
assay
employ
current
studi
modif
method
describ
hoffman
et
al
mdm
cell
valu
shown
reflect
averag
duplic
sampl
differ
author
declar
compet
interest
ts
mp
design
conduct
experi
analyz
data
wrote
manuscript
equal
contribut
cl
fs
perform
experi
analyz
data
kc
cb
coordin
studi
analyz
data
involv
write
manuscript
author
read
approv
final
manuscript
